Our results indicate that NRP1 may regulate the EMT process in OSCC cell lines through NF-κB activation, and that higher NRP1 expression levels are associated with lymph node metastasis and poor prognosis in OSCC patients. This evidence concerns the gene NRP1 and metastatic malignant neoplasm in the lymph nodes.